About this Research Topic
Liver cancer represents a major global health burden, ranking as the sixth most prevalent malignant tumor worldwide and the fourth leading cause of cancer-related mortality. Addressing this, the current research focus has shifted towards more integrated treatment modalities aiming to combine surgical interventions with targeted immunotherapy. Despite the proven effectiveness of surgery in reducing tumor mass, the heterogeneity of liver cancer and its escalating incidence rate necessitate a more versatile approach, making the combination of surgical and immunotherapeutic strategies increasingly essential. This synergy allows for the effective removal of bulky disease via surgery and employs the host's immune response to eradicate residual microscopic disease, enhancing overall treatment efficacy.
This Research Topic aims to evaluate the latest advancements in both basic and clinical research concerning liver cancer, examining the collaborative effects of surgery and targeted immunotherapy. It seeks to uncover how these dual strategies can be optimized for comprehensive treatment applications, potentially setting new standards in patient care. The goal is to catalyze innovation, offering new insights and practical guidance for both surgeons and oncologists involved in liver cancer management.
To expand the current understanding and application of these integrated treatment strategies, this research topic calls for the submission of high-quality research papers and review articles. We particularly encourage works that focus on innovative surgical techniques for liver tumor management and the refinement of targeted immunotherapy. Contributions may include, but are not limited to, the following themes:
• Surgical treatment of liver cancer
• Novel surgical interventions to treat liver cancer
• Refinements to existing surgical interventions leading to improved patient outcomes
• Novel agents or regimens for liver cancer, including targeted therapy and immunotherapy
This Research Topic aims to evaluate the latest advancements in both basic and clinical research concerning liver cancer, examining the collaborative effects of surgery and targeted immunotherapy. It seeks to uncover how these dual strategies can be optimized for comprehensive treatment applications, potentially setting new standards in patient care. The goal is to catalyze innovation, offering new insights and practical guidance for both surgeons and oncologists involved in liver cancer management.
To expand the current understanding and application of these integrated treatment strategies, this research topic calls for the submission of high-quality research papers and review articles. We particularly encourage works that focus on innovative surgical techniques for liver tumor management and the refinement of targeted immunotherapy. Contributions may include, but are not limited to, the following themes:
• Surgical treatment of liver cancer
• Novel surgical interventions to treat liver cancer
• Refinements to existing surgical interventions leading to improved patient outcomes
• Novel agents or regimens for liver cancer, including targeted therapy and immunotherapy
Keywords: Liver cancer, Surgical operation, Targeted therapy, Immunotherapy, Clinical research, Basic research
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
